GMVD
Income statement / Annual
Last year (2022), G Medical Innovations Holdings Ltd's total revenue was $4.42 M,
a decrease of 12.61% from the previous year.
In 2022, G Medical Innovations Holdings Ltd's net income was -$13.96 M.
See G Medical Innovations Holdings Ltd’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
09/30/2016 |
| Operating Revenue |
$4.42 M
|
$5.06 M
|
$4.90 M
|
$5.53 M
|
$3.06 M
|
$109,000.00
|
$0.00
|
| Cost of Revenue |
$3.64 M |
$3.56 M |
$4.23 M |
$5.75 M |
$4.03 M |
$1.16 M |
$0.00 |
| Gross Profit |
$784,000.00 |
$1.50 M |
$667,000.00 |
-$223,000.00 |
-$969,000.00 |
-$1.05 M |
$0.00 |
| Gross Profit Ratio |
0.18 |
0.3 |
0.14 |
-0.04 |
-0.32 |
-9.6 |
0 |
| Research and Development
Expenses |
$2.29 M
|
$1.68 M
|
$1.32 M
|
$2.55 M
|
$243,000.00
|
$186,000.00
|
$0.00
|
| General & Administrative
Expenses |
$24.86 M
|
$9.01 M
|
$7.66 M
|
$10.00 M
|
$12.61 M
|
$24.01 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$3.46 M
|
$664,000.00
|
$356,000.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$24.86 M
|
$9.01 M
|
$7.66 M
|
$10.00 M
|
$13.27 M
|
$24.36 M
|
$0.00
|
| Other Expenses |
$1.05 M |
$854,000.00 |
$3.70 M |
$0.00 |
$2.70 M |
$0.00 |
$0.00 |
| Operating Expenses |
$28.19 M |
$11.54 M |
$12.67 M |
$12.56 M |
$16.22 M |
$25.48 M |
$0.00 |
| Cost And Expenses |
$31.83 M |
$15.10 M |
$16.90 M |
$18.30 M |
$28.69 M |
$26.63 M |
$0.00 |
| Interest Income |
$0.00 |
$870,000.00 |
$344,000.00 |
$263,000.00 |
$858,000.00 |
$282,000.00 |
$0.00 |
| Interest Expense |
$0.00 |
$4.49 M |
$750,000.00 |
$3.85 M |
$995,000.00 |
$923,000.00 |
$0.00 |
| Depreciation &
Amortization |
-$10.34 M
|
$1.00 M
|
$3.61 M
|
$2.01 M
|
$2.61 M
|
$176,000.00
|
$22,816.00
|
| EBITDA |
-$37.75 M
|
-$9.04 M
|
-$8.40 M
|
-$12.52 M
|
-$13.71 M
|
-$26.06 M
|
$0.00
|
| EBITDA Ratio |
-8.54 |
-1.79 |
-1.71 |
-2.26 |
-4.48 |
-239.11 |
0 |
| Operating Income Ratio
|
-6.2
|
-1.98
|
-2.45
|
-2.63
|
-5.33
|
-240.72
|
0
|
| Total Other
Income/Expenses Net |
$13.47 M
|
-$3.62 M
|
-$702,000.00
|
-$3.58 M
|
-$137,000.00
|
-$923,000.00
|
$0.00
|
| Income Before Tax |
-$13.94 M |
-$14.89 M |
-$12.71 M |
-$16.36 M |
-$17.32 M |
-$27.16 M |
$0.00 |
| Income Before Tax Ratio
|
-3.15
|
-2.94
|
-2.59
|
-2.96
|
-5.66
|
-249.19
|
0
|
| Income Tax Expense |
$16,000.00 |
-$3,000.00 |
-$18,000.00 |
-$857,000.00 |
-$345,000.00 |
$85,000.00 |
$0.00 |
| Net Income |
-$13.96 M |
-$14.89 M |
-$12.69 M |
-$15.51 M |
-$16.98 M |
-$27.25 M |
$0.00 |
| Net Income Ratio |
-3.16 |
-2.94 |
-2.59 |
-2.81 |
-5.54 |
-249.97 |
0 |
| EPS |
0 |
-45.89 |
-60.4 |
-7 |
-8.6 |
-20.39 |
0 |
| EPS Diluted |
0 |
-45.89 |
-60.4 |
-7 |
-8.6 |
-20.39 |
0 |
| Weighted Average Shares
Out |
$0.00
|
$324,452.00
|
$210,070.00
|
$2.21 M
|
$1.97 M
|
$1.34 M
|
$71.11 M
|
| Weighted Average Shares
Out Diluted |
$0.00
|
$324,452.00
|
$210,070.00
|
$2.21 M
|
$1.97 M
|
$1.34 M
|
$71.11 M
|
| Link |
|
|
|
|
|
|
|
